fbpx
Saturday, January 23, 2021

Israeli Biotech Company Starts Clinical Trials of CBD-Steroid Treatment for COVID-19

Ten patients will be included at the start; the treatment cycle will be for a few weeks with a follow-up period of the same length.

Print This Article

The Israel-based biotech company Stero Biotechs has started a small-scale clinical trial at Rabin Medical Center’s Golda Hasharon Campus in Petach Tikvah on the effects of a steroid-Cannabidiol (CBD) treatment on hospitalized COVID-19 patients.

“Steroid treatment is usually the first or second line of treatment for hospitalized patients. CBD enhances the therapeutic effect of steroid treatment and treats the bio-mechanism affected by the virus,” the company said in a press release announcing the clinical trial. “The initial study will evaluate the tolerability, safety and efficacy of the CBD treatment for hospitalized patients with COVID-19 Infections.”

Ten patients will be in the clinical trial; the treatment cycle will be for a few weeks with a follow-up period of the same length. Pending the trial’s success, the company plans to expand to a multi-center clinical trial with an additional 40 hospitalized COVID-19 patients, under FDA clinical trial guidelines and regulations.

“We estimate that our CBD-based treatment can enhance the current treatment of those patients who are suffering life-threatening conditions,” said Stero Biotechs founder and CEO David Bassa.

“Hospitalized COVID-19 patients are mostly being treated with steroids, and our study is planned to demonstrate the benefit of a combined solution with steroid treatments,” he continued. “We are hopeful that this study will lead to faster benefit for the growing number of COVID-19 patients in Israel and around the world.”

Stero Biotechs, founded in 2017 and headquartered in Israel, is a clinical-stage company that focuses on the research and development of novel CBD-based treatment solutions.

Did you enjoy this article?

You'll love our roundtable.

Enjoyed this article?

You'll love our roundtable.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Jewish Journal, 3250 Wilshire Boulevard, Los Angeles, CA, 90010, http://www.jewishjournal.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Essays and Columns of 2020

Latest Articles

Culture

Latest Articles
Latest

Trust and Action: The US president’s First 100 Days

The first days of any new job are difficult, but critical—for the president of the United States more than for anyone else on the planet, perhaps.

Andrew Yang Says BDS Harkens ‘Back to Fascist Boycotts of Jewish Businesses’

New York City Mayoral Candidate Andrew Yang wrote in The Forward that the Boycott, Divestment and Sanctions (BDS) movement harkens “back to fascist boycotts...

Can the Latest American Political Hit Squad Decide Israel’s Election?

The Lincoln Project was one of the biggest winners of the 2020 presidential election.

The Power of Example

President Biden wasn’t elected because of his soaring rhetoric — he was chosen because of the power of his example.

CA State Bar Won’t Disbar Lawyer Over Alleged Anti-Semitic Posts

The State Bar of California has said that they won’t disbar a lawyer who is currently under fire for making allegedly anti-Semitic social media...

Hollywood

Podcasts

More news and opinions than at a Shabbat dinner, right in your inbox.

x